Novartis AG Cash Flows From Used In Financing Activities Continuing Operations
Novartis AG (NVS) reported Cash Flows From Used In Financing Activities Continuing Operations of -$14.87 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations · last filed 2026-02-04
- Novartis AG cash flows from used in financing activities continuing operations for the quarter ending 2024-06-30 was -$3.20B.
- Novartis AG cash flows from used in financing activities continuing operations for the quarter ending 2023-06-30 was -$3.77B.
- Novartis AG cash flows from used in financing activities continuing operations for the quarter ending 2022-06-30 was -$2.30B.
- Novartis AG cash flows from used in financing activities continuing operations for the quarter ending 2021-06-30 was -$2.94B.
| Period end | Cash Flows From Used In Financing Activities Continuing Operations 3 month | Cash Flows From Used In Financing Activities Continuing Operations 6 month | Cash Flows From Used In Financing Activities Continuing Operations 12 month | Cash Flows From Used In Financing Activities Continuing Operations 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$14.87B 20-F · filed 2026-02-04 | |||
| 2024-12-31 | -$11.74B 20-F · filed 2026-02-04 | |||
| 2024-06-30 | -$3.20B 6-K · filed 2024-07-18 | -$8.36B 6-K · filed 2024-07-18 | ||
| 2023-12-31 | -$17.56B 20-F · filed 2026-02-04 | |||
| 2023-06-30 | -$3.77B 6-K · filed 2024-07-18 | -$12.76B 6-K · filed 2024-07-18 | ||
| 2022-12-31 | -$20.68B 20-F · filed 2025-01-31 | -$20.56B 20-F · filed 2023-02-01 | ||
| 2022-06-30 | -$2.30B 6-K · filed 2022-07-19 | -$11.83B 6-K · filed 2022-07-19 | ||
| 2021-12-31 | -$16.29B 20-F · filed 2024-01-31 | -$16.26B 20-F · filed 2022-02-02 | ||
| 2021-06-30 | -$2.94B 6-K · filed 2022-07-19 | -$11.46B 6-K · filed 2022-07-19 | ||
| 2020-12-31 | -$2.16B 20-F/A · filed 2023-05-15 | |||
| 2020-06-30 | -$2.17B 6-K · filed 2021-07-21 | -$1.15B 6-K · filed 2021-07-21 | ||
| 2019-12-31 | -$16.88B 20-F · filed 2022-02-02 | |||
| 2019-06-30 | -$2.71B 6-K · filed 2020-07-21 | -$13.01B 6-K · filed 2020-07-21 | ||
| 2018-12-31 | -$4.08B 20-F · filed 2021-01-26 | |||
| 2018-06-30 | -$1.27B 6-K · filed 2019-07-18 | -$2.76B 6-K · filed 2019-07-18 | ||
| 2017-12-31 | -$7.32B 20-F · filed 2020-01-29 |